ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.
From time-to-time ASH calls on its members to reach out to Congress and state legislatures on issues of importance to hematologists and their patients.
Become an advocate for hematology and learn many ways you can make a difference – from how to email Congress to using social media to reach your elected officials, the Advocacy Toolkit offers a road map for everything you need to know in advocating for hematology.
In 2015, ASH launched the Sickle Cell Disease (SCD) Initiative. The Society has since made advocating for policies to improve outcomes for individuals living with SCD a core priority. ASH works with federal agencies, including leaders at the U.S. Department of Health and Human Services, and the U.S. Congress to help enhance and expand government activities in SCD research, training, and services.
ASH continues to be a highly visible advocate for federal support of biomedical research and public health funding, including funding for the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Health Resources and Services Administration (HRSA). ASH and other members of the biomedical research and public health communities continue to strongly urge Congress to provide increased annual funding for NIH, CDC and other federal public health agencies and programs- increased resources are needed now more than ever due to the COVID-19 pandemic.